Michael O Idowu

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersFeminist methodologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 15, 2025
Targeting Bcl-xL to eliminate chemotherapy-induced tumor dormancy and prevent breast cancer metastasis.

Kinjal Gupta, Nicholas Koelsch, Victoria Neely

|Nov 10, 2023
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma.

Kranthi Kumar Chougoni, Haemin Park, Priyadarshan K Damle

|Nov 26, 2022
Alpha-1 Antitrypsin Inhibits Tumorigenesis and Progression of Colitis-Associated Colon Cancer through Suppression of Inflammatory Neutrophil-Activated Serine Proteases and IGFBP-3 Proteolysis.

Qing Cai, Minsun Kim, Aki Harada

|Oct 25, 2022
Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer.

Rania Bassiouni, Michael O Idowu, Lee D Gibbs

|Mar 27, 2021
The human intermediate prolactin receptor is a mammary proto-oncogene.

Jacqueline M Grible, Patricija Zot, Amy L Olex

Pageof 1

Frequent Collaborators

1 joint publications

Charles V Clevenger

1 joint publications

Rania Bassiouni

1 joint publications

Lee D Gibbs

1 joint publications

Valentina Robila